世界の間葉系幹細胞市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC06223)
◆英語タイトル:Global Mesenchymal Stem Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC06223
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、間葉系幹細胞の世界市場を調査対象にし、間葉系幹細胞の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ヒトMSC、マウスMSC、ラットMSC、その他)、用途別分析(研究所、病院、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Lonza、Celprogen、ATCC、Thermo Fisher、Genlantis、Bio-Techne、Cyagen Biosciences、PromoCell GmbH、MilliporeSigma、Cell Applications
・企業別売上、市場シェア
・間葉系幹細胞の地域別市場分析
・間葉系幹細胞の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・間葉系幹細胞のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・間葉系幹細胞のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・間葉系幹細胞の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・間葉系幹細胞の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・間葉系幹細胞の種類別市場規模2015-2020:ヒトMSC、マウスMSC、ラットMSC、その他
・間葉系幹細胞の用途別市場規模2015-2020:研究所、病院、その他
・間葉系幹細胞の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The Mesenchymal Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Mesenchymal Stem Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 231.8 million by 2025, from USD 195.8 million in 2019.

Market segmentation
Mesenchymal Stem Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Mesenchymal Stem Cells market has been segmented into:
Human MSC
Mouse MSC
Rat MSC
Other

By Application, Mesenchymal Stem Cells has been segmented into:
Research Institute
Hospital
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Mesenchymal Stem Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Mesenchymal Stem Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Mesenchymal Stem Cells market.

The report offers in-depth assessment of the growth and other aspects of the Mesenchymal Stem Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Mesenchymal Stem Cells Market Share Analysis
Mesenchymal Stem Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Mesenchymal Stem Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Mesenchymal Stem Cells sales, revenue and market share for each player covered in this report.

The major players covered in Mesenchymal Stem Cells are:
Lonza
Celprogen
ATCC
Thermo Fisher
Genlantis
Bio-Techne
Cyagen Biosciences
PromoCell GmbH
MilliporeSigma
Cell Applications
Among other players domestic and global, Mesenchymal Stem Cells market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Mesenchymal Stem Cells Market Overview
1.1 Product Overview and Scope of Mesenchymal Stem Cells
1.2 Classification of Mesenchymal Stem Cells by Type
1.2.1 Global Mesenchymal Stem Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Mesenchymal Stem Cells Revenue Market Share by Type in 2019
1.2.3 Human MSC
1.2.4 Mouse MSC
1.2.5 Rat MSC
1.2.6 Other
1.3 Global Mesenchymal Stem Cells Market by Application
1.3.1 Overview: Global Mesenchymal Stem Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Institute
1.3.3 Hospital
1.3.4 Others
1.4 Global Mesenchymal Stem Cells Market by Regions
1.4.1 Global Mesenchymal Stem Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Mesenchymal Stem Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Mesenchymal Stem Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Mesenchymal Stem Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mesenchymal Stem Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Mesenchymal Stem Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mesenchymal Stem Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza SWOT Analysis
2.1.4 Lonza Product and Services
2.1.5 Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celprogen
2.2.1 Celprogen Details
2.2.2 Celprogen Major Business
2.2.3 Celprogen SWOT Analysis
2.2.4 Celprogen Product and Services
2.2.5 Celprogen Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 ATCC
2.3.1 ATCC Details
2.3.2 ATCC Major Business
2.3.3 ATCC SWOT Analysis
2.3.4 ATCC Product and Services
2.3.5 ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher
2.4.1 Thermo Fisher Details
2.4.2 Thermo Fisher Major Business
2.4.3 Thermo Fisher SWOT Analysis
2.4.4 Thermo Fisher Product and Services
2.4.5 Thermo Fisher Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 Genlantis
2.5.1 Genlantis Details
2.5.2 Genlantis Major Business
2.5.3 Genlantis SWOT Analysis
2.5.4 Genlantis Product and Services
2.5.5 Genlantis Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Techne
2.6.1 Bio-Techne Details
2.6.2 Bio-Techne Major Business
2.6.3 Bio-Techne Product and Services
2.6.4 Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cyagen Biosciences
2.7.1 Cyagen Biosciences Details
2.7.2 Cyagen Biosciences Major Business
2.7.3 Cyagen Biosciences Product and Services
2.7.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 PromoCell GmbH
2.8.1 PromoCell GmbH Details
2.8.2 PromoCell GmbH Major Business
2.8.3 PromoCell GmbH Product and Services
2.8.4 PromoCell GmbH Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 MilliporeSigma
2.9.1 MilliporeSigma Details
2.9.2 MilliporeSigma Major Business
2.9.3 MilliporeSigma Product and Services
2.9.4 MilliporeSigma Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cell Applications
2.10.1 Cell Applications Details
2.10.2 Cell Applications Major Business
2.10.3 Cell Applications Product and Services
2.10.4 Cell Applications Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Mesenchymal Stem Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Mesenchymal Stem Cells Players Market Share
3.2.2 Top 10 Mesenchymal Stem Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Mesenchymal Stem Cells Revenue and Market Share by Regions
4.2 North America Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
4.5 South America Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
5 North America Mesenchymal Stem Cells Revenue by Countries
5.1 North America Mesenchymal Stem Cells Revenue by Countries (2015-2020)
5.2 USA Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
6 Europe Mesenchymal Stem Cells Revenue by Countries
6.1 Europe Mesenchymal Stem Cells Revenue by Countries (2015-2020)
6.2 Germany Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
6.3 UK Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
6.4 France Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Mesenchymal Stem Cells Revenue by Countries
7.1 Asia-Pacific Mesenchymal Stem Cells Revenue by Countries (2015-2020)
7.2 China Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
7.5 India Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
8 South America Mesenchymal Stem Cells Revenue by Countries
8.1 South America Mesenchymal Stem Cells Revenue by Countries (2015-2020)
8.2 Brazil Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Mesenchymal Stem Cells by Countries
9.1 Middle East & Africa Mesenchymal Stem Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Mesenchymal Stem Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Mesenchymal Stem Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Mesenchymal Stem Cells Market Forecast by Type (2019-2024)
10.3 Human MSC Revenue Growth Rate (2015-2025)
10.4 Mouse MSC Revenue Growth Rate (2015-2025)
10.5 Rat MSC Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Mesenchymal Stem Cells Market Segment by Application
11.1 Global Mesenchymal Stem Cells Revenue Market Share by Application (2015-2020)
11.2 Mesenchymal Stem Cells Market Forecast by Application (2019-2024)
11.3 Research Institute Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Mesenchymal Stem Cells Market Size Forecast (2021-2025)
12.1 Global Mesenchymal Stem Cells Market Size Forecast (2021-2025)
12.2 Global Mesenchymal Stem Cells Market Forecast by Regions (2021-2025)
12.3 North America Mesenchymal Stem Cells Revenue Market Forecast (2021-2025)
12.4 Europe Mesenchymal Stem Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Mesenchymal Stem Cells Revenue Market Forecast (2021-2025)
12.6 South America Mesenchymal Stem Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Mesenchymal Stem Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の間葉系幹細胞市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Mesenchymal Stem Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。